Bilcare Ltd

Bilcare Ltd, a micro-cap player in the Healthcare Services sector, has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating. Despite recent price declines and underperformance relative to the Sensex, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more compelling entry point for investors seeking value in a challenging market environment.

Bilcare Ltd, a micro-cap player in the Healthcare Services sector, has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid subdued financial performance and challenging sector dynamics, prompting a reassessment of its price attractiveness relative to peers and historical benchmarks.

Bilcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 02 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Bilcare Ltd has witnessed a notable shift in its valuation parameters, moving from a risky to an attractive valuation grade, despite lingering challenges in profitability metrics. This recalibration in price-to-earnings and price-to-book ratios, alongside peer comparisons, offers investors a fresh perspective on the stock’s price attractiveness within the healthcare services sector.

Bilcare Ltd, a micro-cap player in the Healthcare Services sector, has demonstrated a notable improvement in its financial performance for the quarter ended March 2026, signalling a positive shift in its financial trend after a period of stagnation. Despite this, the company’s stock continues to face challenges in the broader market context, with returns lagging behind benchmark indices over the year-to-date and one-year periods.

Bilcare Ltd., a speciality pharmaceutical packaging barrier films manufacturer, reported a dramatic quarterly profit turnaround in Q4 FY26 with consolidated net profit of ₹13.37 crores, marking a staggering 1278.35% quarter-on-quarter surge from ₹0.97 crores in Q3 FY26. However, the year-on-year comparison reveals a 23.95% decline from ₹17.58 crores in Q4 FY25, highlighting persistent challenges beneath the surface-level recovery. The stock, currently trading at ₹63.20 with a micro-cap market capitalisation of ₹155.00 crores, has underperformed significantly over the past year with a 23.14% decline against the Sensex's 8.82% fall.

Bilcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 25 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

At Rs 51.62, Bilcare Ltd saw sellers queue relentlessly with no buyers stepping in, resulting in the stock locking at its lower circuit limit of 20% on 18 May 2026. This freeze in trading reflects unfilled supply and a market unable to absorb the selling pressure.

Bilcare Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating downgraded from Sell to Strong Sell as of 13 May 2026. This shift reflects deteriorating technical indicators, flat financial performance, and persistent fundamental weaknesses, signalling heightened risk for investors despite recent short-term price gains.

Bilcare Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 8 May 2026. This change is primarily driven by a shift in technical indicators, even as the company continues to grapple with weak financial fundamentals and valuation concerns. The nuanced upgrade reflects a complex interplay of quality, valuation, financial trends, and technical signals that investors should carefully consider.

Bilcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 08 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Bilcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 April 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Bilcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Bilcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 April 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Despite a modest rebound over the past two sessions, Bilcare Ltd has slipped to a fresh 52-week low of Rs 51 on 27 Mar 2026, marking a 56.0% decline from its peak of Rs 116 within the last year. This decline contrasts sharply with the broader market, where the Sensex, although down sharply, remains 3.52% above its own 52-week low. The stock’s persistent weakness raises questions about the underlying factors weighing on this micro-cap healthcare services company.

Bilcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 18 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 March 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.

While the broader market showed signs of recovery, Bilcare Ltd slipped to a fresh 52-week low of Rs 51.75 on 24 Mar 2026, extending a challenging period for the healthcare services company amid persistent headwinds.